Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107597037> ?p ?o ?g. }
- W2107597037 abstract "OBJECTIVENo well-controlled studies of the safety and efficacy of active vitamin D analogues have been conducted in vitamin D-replete (25-hydroxyvitamin D ≥ 30 ng/mL) patients. This study assessed the safety and efficacy of doxercalciferol in vitamin D-replete patients with secondary hyperparathyroidism.METHODSThis was a randomized, double-blind, placebo-controlled, parallel study. Twenty-four vitamin D-replete (exogenous ergocalciferol or intrinsically replete) patients with elevated intact parathyroid hormone (iPTH) were randomized to receive doxercalciferol or matching placebo capsules for 24 weeks. The dose was regularly titrated to achieve target iPTH levels (CKD Stage 3: ≤ 70 pg/mL; CKD Stage 4: ≤ 110 pg/mL).RESULTSEleven (92%) doxercalciferol patients met the iPTH target range at least once post randomization compared with four (33%) placebo patients. All 12 (100%) doxercalciferol patients achieved a 30% reduction in iPTH at least once post randomization, and more doxercalciferol patients (83%) maintained iPTH within the target range for up to 6 weeks compared with the placebo patients (17%). Doxercalciferol and placebo were well tolerated during the study. No adverse events of hypercalcemia were reported.CONCLUSIONSDoxercalciferol was well tolerated and effective in reducing iPTH in vitamin D-replete CKD patients without accompanying hypercalcemia. Further studies in a larger population of vitamin D-replete patients are needed." @default.
- W2107597037 created "2016-06-24" @default.
- W2107597037 creator A5005130427 @default.
- W2107597037 creator A5012336427 @default.
- W2107597037 creator A5012675529 @default.
- W2107597037 creator A5023599600 @default.
- W2107597037 creator A5025408601 @default.
- W2107597037 creator A5033158703 @default.
- W2107597037 creator A5038917914 @default.
- W2107597037 creator A5058789020 @default.
- W2107597037 creator A5077514410 @default.
- W2107597037 date "2011-06-01" @default.
- W2107597037 modified "2023-09-27" @default.
- W2107597037 title "Double-blind study comparing doxercalciferol and placebo in vitamin D-replete CKD patients" @default.
- W2107597037 cites W1531471974 @default.
- W2107597037 cites W1993858578 @default.
- W2107597037 cites W2018567109 @default.
- W2107597037 cites W2031941775 @default.
- W2107597037 cites W2033305400 @default.
- W2107597037 cites W2092781739 @default.
- W2107597037 cites W4231263233 @default.
- W2107597037 doi "https://doi.org/10.1002/dat.20583" @default.
- W2107597037 hasPublicationYear "2011" @default.
- W2107597037 type Work @default.
- W2107597037 sameAs 2107597037 @default.
- W2107597037 citedByCount "0" @default.
- W2107597037 crossrefType "journal-article" @default.
- W2107597037 hasAuthorship W2107597037A5005130427 @default.
- W2107597037 hasAuthorship W2107597037A5012336427 @default.
- W2107597037 hasAuthorship W2107597037A5012675529 @default.
- W2107597037 hasAuthorship W2107597037A5023599600 @default.
- W2107597037 hasAuthorship W2107597037A5025408601 @default.
- W2107597037 hasAuthorship W2107597037A5033158703 @default.
- W2107597037 hasAuthorship W2107597037A5038917914 @default.
- W2107597037 hasAuthorship W2107597037A5058789020 @default.
- W2107597037 hasAuthorship W2107597037A5077514410 @default.
- W2107597037 hasBestOaLocation W21075970371 @default.
- W2107597037 hasConcept C124490489 @default.
- W2107597037 hasConcept C126322002 @default.
- W2107597037 hasConcept C126894567 @default.
- W2107597037 hasConcept C142724271 @default.
- W2107597037 hasConcept C168563851 @default.
- W2107597037 hasConcept C197934379 @default.
- W2107597037 hasConcept C202061045 @default.
- W2107597037 hasConcept C204243189 @default.
- W2107597037 hasConcept C204787440 @default.
- W2107597037 hasConcept C27081682 @default.
- W2107597037 hasConcept C2775945674 @default.
- W2107597037 hasConcept C2776079296 @default.
- W2107597037 hasConcept C2776940978 @default.
- W2107597037 hasConcept C2777621572 @default.
- W2107597037 hasConcept C2778838027 @default.
- W2107597037 hasConcept C2779740938 @default.
- W2107597037 hasConcept C2780106736 @default.
- W2107597037 hasConcept C2781208988 @default.
- W2107597037 hasConcept C2908647359 @default.
- W2107597037 hasConcept C2991744798 @default.
- W2107597037 hasConcept C519063684 @default.
- W2107597037 hasConcept C71924100 @default.
- W2107597037 hasConcept C99454951 @default.
- W2107597037 hasConceptScore W2107597037C124490489 @default.
- W2107597037 hasConceptScore W2107597037C126322002 @default.
- W2107597037 hasConceptScore W2107597037C126894567 @default.
- W2107597037 hasConceptScore W2107597037C142724271 @default.
- W2107597037 hasConceptScore W2107597037C168563851 @default.
- W2107597037 hasConceptScore W2107597037C197934379 @default.
- W2107597037 hasConceptScore W2107597037C202061045 @default.
- W2107597037 hasConceptScore W2107597037C204243189 @default.
- W2107597037 hasConceptScore W2107597037C204787440 @default.
- W2107597037 hasConceptScore W2107597037C27081682 @default.
- W2107597037 hasConceptScore W2107597037C2775945674 @default.
- W2107597037 hasConceptScore W2107597037C2776079296 @default.
- W2107597037 hasConceptScore W2107597037C2776940978 @default.
- W2107597037 hasConceptScore W2107597037C2777621572 @default.
- W2107597037 hasConceptScore W2107597037C2778838027 @default.
- W2107597037 hasConceptScore W2107597037C2779740938 @default.
- W2107597037 hasConceptScore W2107597037C2780106736 @default.
- W2107597037 hasConceptScore W2107597037C2781208988 @default.
- W2107597037 hasConceptScore W2107597037C2908647359 @default.
- W2107597037 hasConceptScore W2107597037C2991744798 @default.
- W2107597037 hasConceptScore W2107597037C519063684 @default.
- W2107597037 hasConceptScore W2107597037C71924100 @default.
- W2107597037 hasConceptScore W2107597037C99454951 @default.
- W2107597037 hasLocation W21075970371 @default.
- W2107597037 hasOpenAccess W2107597037 @default.
- W2107597037 hasPrimaryLocation W21075970371 @default.
- W2107597037 hasRelatedWork W2001320196 @default.
- W2107597037 hasRelatedWork W2034787549 @default.
- W2107597037 hasRelatedWork W2036132254 @default.
- W2107597037 hasRelatedWork W2068692960 @default.
- W2107597037 hasRelatedWork W2088163390 @default.
- W2107597037 hasRelatedWork W2110497847 @default.
- W2107597037 hasRelatedWork W2110553860 @default.
- W2107597037 hasRelatedWork W2114962014 @default.
- W2107597037 hasRelatedWork W2136486000 @default.
- W2107597037 hasRelatedWork W2138393701 @default.
- W2107597037 hasRelatedWork W2314596074 @default.
- W2107597037 hasRelatedWork W2337757926 @default.
- W2107597037 hasRelatedWork W2587629762 @default.
- W2107597037 hasRelatedWork W2765316750 @default.